AI and blood tests aim to replace risky liver biopsies
Diagnosis
Recruiting now
This study aims to find better, non-invasive ways to diagnose liver scarring (fibrosis) in people with fatty liver disease. Researchers will collect blood samples from 575 participants and compare new blood tests and AI-powered ultrasound to the current gold standard, a liver bio…
Sponsor: Roche Diagnostics GmbH • Aim: Diagnosis
Last updated Apr 02, 2026 00:56 UTC